Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Rejlers acquires DynaMate's consultancy division

Through the agreement with Scania-owned DynaMate, Rejlers Sweden is adding to its expertise within HVAC and other key areas and further strengthening the services it offers within safety. In total, 31 employees will transfer to Rejlers’ offices in Luleå, Stockholm, Borlänge and Oskarshamn with effect from 1 April.DynaMate, a Scania subsidiary, has actively been searching for a suitable buyer for its consultancy division. Rejlers has worked with DynaMate on a number of projects in Luleå and elsewhere, and both companies are very familiar with each other’s operations. “The consultancy

4 MW platform’s flexibility secures 72 MW order in Sweden from long-term customer Stena Renewable AB

Long-term customer Stena Renewable AB has placed a 72 MW order for two projects in southern Sweden. Utilising the 4 MW platform’s flexibility, Vestas will deliver 16 V136-3.45 MW turbines with 3.6 MW Power Optimised Mode specifically increased to 3.8 MW for the Kronoberget wind power project, and 3 V136-3.45 MW turbines in 3.6 MW Power Optimised Mode for the Fjällberget wind project.  The V136-3.45 MW’s different power modes and the full use of permitted total heights ensure a high capacity factor and maximise energy production at both sites based on the specific wind conditions. Today’s

Quit smoking, nicotine free: Oriola to distribute Acetium® lozenge in Finland

Biohit Oyj, Press release, March 12, 2018 at 10:30 am local time (EET) Biohit Oyj and Oriola Oy have signed an agreement for the distribution of the smoking cessation product, Acetium lozenge in Pharmacies and other Oriola sales channels in Finland. Launch date for the product will be announced later. The new Acetium lozenge is an effective and safe product that helps quit smoking without nicotine or any of the potential side-effects of medicinal intervention methods. Acetium lozenge is used during smoking and it eliminates cigarette smoke-derived carcinogenic acetaldehyde in the

Eltel signs a letter of intent to divest its rail operations in Sweden

Eltel has today signed a letter of intent to divest its Swedish rail operations, consisting of key customer contracts, employees and operational equipment, to Strukton Rail AB, a company providing solutions in rail infrastructure, railway vehicles and mobility systems.The contemplated transaction, comprising build and maintenance contracts with key customers, employees and operational equipment used for delivering the relevant services, will have a negative EBITA and negative cash flow effect each estimated to be approximately EUR 6.5 million, to occur at the time of completion of the

HiQ grows in eHealth

HiQ is becoming increasingly important as a player in the field of eHealth. New assignments have seen oureHealth team expand to more than 50 consultants, only in Stockholm, with specialist expertise in the areas of health and medical care. “We’re passionate about using technology to make people’s everyday lives a little simpler – and when it comes to eHealth solutions, the benefits we can bring are particularly clear,” says Magnus Gudéhn, Managing Director of HiQ Stockholm.HiQ’s business area Healthcare is maintaining its record of strong growth. With major deliveries to the Swedish

Extension of Contract with TechnipFMC

Solstad Farstad ASA (SOFF) and TechnipFMC have agreed to extend the Frame Agreement covering the provision of vessels for ploughing and trenching operations for one year. The Frame Agreement is now valid until 31st December 2019. “We have been working closely with TechnipFMC since 1997 and are excited that they once again have trusted us to continue the delivery of high powered vessels to support their ploughing and trenching operations.” says Hans Knut Skår, EVP – Subsea Constructions & Renewable of Solstad Farstad ASA. Skudeneshavn, March 12th 2018 ContactsLars Peder Solstad

#18-432 Change of symbol on instrument issued by Natixis Structured Issuance SA

Per request from issuer, 1 instrument issued by Natixis Structured Issuance SA listed on Miscellaneous Investment Products MTF SE will change symbol as of March 13, 2018.Issuer: Natixis Structured Issuance SA Agent: Exceed For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se Nordic Growth Market NGM AB About NGM Nordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned

CryptoLoan launches disruptive blockchain lending product – Bitcoin-secured loans

Observing the blockchain boom and growing interest from investors’ over the past few months, an alternative financial services provider VIA SMS Group has developed a solution to support Bitcoin investors with an extra asset liquidity. CryptoLoan is a smart lending product offering Bitcoin-secured online loans that will allow Bitcoin investors to enjoy the value of crypto assets without selling them. The new product initially will be available for Swedish residents only, but the company is planning to open registration for other European countries shortly. CryptoLoan is the first product of

Nightingale Health and THL Biobank to accelerate personalized medicine by analyzing 40,000 blood samples

Nightingale Health, the Finnish innovator of an internationally recognized biomarker testing technology for chronic disease screening, will analyze 40,000 blood samples from Finland’s largest biobank, THL Biobank, acting under the National Institute for Health and Welfare (THL). This initiative signifies a step towards bringing personalized medicine to Finnish healthcare. Until recently, prohibitive costs and time constraints have prevented analysis of comprehensive metabolic data from large-scale biobank collections but this process has now been made viable by Nightingale’s technology.

Bittium exhibits its innovative R&D services for IoT; and medical technology products at Wearable Technology Show 2018 in London

Press release Free for release on March 12, 2018 at 10am (CET +1) Bittium exhibits its innovative R&D services for IoT; and medical technology products at Wearable Technology Show 2018 in London Bittium’s presentation discusses about medical remote monitoring in the 5G era Oulu, Finland, March 12, 2018 – Bittium exhibits its innovative R&D services for IoT (Internet of Things); and medical technology products at Wearable Technology Show 2018 , to be held in ExCel, London, the United Kingdom on March 13–14, 2017. Bittium’s strong

International attention on IRLAB’s discovery platform

Biomedical Advances publishes a summary of IRLAB’s research and discovery platform, The Integrative Screening Process, ISP, with the motivation ”your paper has been selected to be featured in Biomedical Advances, because of its innovation and potential for significant impact”ISP is a unique discovery platform designed for efficient discovery of novel treatment strategies for neurological and neuropsychiatric disorders. The paper featured by Biomedical Advances describes the application of IRLAB’s in vivo systems response profiling for CNS drug discovery through the process referred to as

Immunovia announces financial targets

LUND, Sweden - The Board of Directors of Immunovia AB (publ) (“Immunovia” or the “Company”) has today adopted financial targets due to the fact the Company, as previously announced, will begin sales during second half of 2018. The financial targets show that the Company’s goal is to reach SEK 250-300 million in turnover in 2021 based on “self-pay”-sales and a turnover of SEK 800-1,000 million in 2023 including self-pay and reimbursements in Europe and the US.Immunovia performs clinical validation studies for the commercialization of IMMray™ PanCan-d, which may be the first blood-based test

Promising clinical results from use of Episealer® will be presented at the annual meeting of British Association for Surgery of the Knee

"Successful clinical results of a focal individualised mini-metal implant for focal cartilage lesions in the knee" by T. Spalding, C. Stevenson, M. Lind, K. Eriksson, T. Jung, G. Histol, P. Emans, and J. Holz has been accepted as a presentation at the BASK (British Association for Surgery of the Knee) annual meeting 2018 in Leicester, UK, which will take place on March 20-21.   The clinical outcome for a European cohort of patients treated with the Episealer® knee implant will be presented.  “We are of course delighted with the fact that clinical results from the use of Episealer®

Scandic establishes a Commercial Paper Program

Scandic has established a Swedish Commercial Paper Program with a total value of 2,000 MSEK.The tenure of issued commercial papers will be between three months and one year. The program will mainly be used for short-term financing of working capital needs and will replace other short-term financing and is estimated to reduce Scandic’s financing costs. The issuer and paying agent for the program is DNB and issuing institutions are DNB, Nordea and Handelsbanken.   For more information, please contact: Henrik Vikström, Director Investor RelationsEmail: henrik.vikstrom@

H&M Foundation invites you to split 1 million euro between five innovations reinventing the fashion industry and protecting the planet

Imagine wearing a coat made of leftovers from harvests of flaxseeds, sugar cane and pineapples, or a t-shirt made of mushroom roots that you decompose in the ground once it’s worn out. Or garments that not only look good, but also nourishes and protects your skin due the nutritious algae it’s made of? These ideas are some of the winners in the third edition of Global Change Award. Now, the non-profit H&M Foundation needs your help to split the 1 million euro grant between the five winners in an online vote on globalchangeaward.com March 12-16.Cast your vote 

Interim report from DIAGNODE-1 shows continued positive clinical course

Diamyd Medical today announced that a sixth interim report from the investigator initiated DIAGNODE-1 trial, an open label clinical pilot trial in which the diabetes vaccine Diamyd® is given directly into the lymph node, shows a continued positive clinical course in terms the patients’ own ability to produce insulin as well as long-term blood sugar and insulin dose when nine patients have been followed for 15 months.In a sixth interim report from the open label investigator initiated clinical pilot trial DIAGNODE-1, where the diabetes vaccine Diamyd® is administered directly into the lymph

NOTICE OF ANNUAL GENERAL MEETING 2018 OF CATENA MEDIA PLC

in accordance with Articles 18 and 19 of the Articles of Association of the Company. NOTICE IS HEREBY GIVEN that the ANNUAL GENERAL MEETING 2018 (the “Meeting”) of Catena Media plc, company registration number C70858 (the “Company” or “Catena”), will be held on Thursday, 26 April 2018, at 09:30 a.m. (CET) at the premises Helio GT30 “Turbine”, Grev Turegatan 30 in Stockholm, Sweden. Attendance and voting · To be entitled to attend and vote at the Meeting (and for the Company to be able to determine the number of votes that may be cast), shareholders must be entered in the register

Pihlajalinna Plc acquires Doctagon Ab through a directed share issue

Pihlajalinna Plc                         Stock exchange release                 12 March 2018 at 9:10 Pihlajalinna Plc acquires Doctagon Ab through a directed share issue Pihlajalinna Plc has signed a share exchange agreement yesterday evening related to the acquisition of the Doctagon Ab’s entire share capital from its current owners. The M&A transaction will be realised through the issuance of Pihlajalinna’s new shares directed to Doctagon Ab’s owners. In the directed share issue, the entire Doctagon Ab’s transaction price EUR 30,105,000 is paid with Pihlajalinna Plc’s shares.

Alimak Group wins MSEK 48 order for BMU system to China

Qingdao CONSON Development Group has placed an order with Alimak Group’s CoxGomyl for a complex building maintenance unit (BMU) system to be placed at the Haitian Center which will be the tallest building in Qingdao, China.The project covers design, manufacturing, installation, testing and commissioning of seven sets of BMUs with an order value of approximately MSEK 48. This is the first project CoxGomyl has been awarded from Qingdao CONSON. The Haitian Center will consist of three towers, with the tallest being 369 metres, and include two five-star hotels, a commercial centre, museum

Altia Plc applies for its shares to be listed on the official list of Nasdaq Helsinki Ltd; the Finnish language prospectus has been published

Altia Plc, Stock Exchange Release, 12 March 2018 at 9:00 a.m. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE’S REPUBLIC OF CHINA, JAPAN, SOUTH AFRICA OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. Altia Plc (“Altia” or the “Company”) has today filed a listing application with Nasdaq Helsinki Ltd (the “Helsinki Stock Exchange”) to list the Company’s shares first on the prelist and then on the official

Notice of the Annual General Meeting of Cloetta AB (publ)

Shareholders of Cloetta AB (publ), 556308-8144, are hereby invited to attend the Annual General Meeting, to be held on Monday, 16 April 2018 at 3:00 p.m. at Stockholm Waterfront Congress Centre, Nils Ericsons Plan 4 in Stockholm, Sweden.Notification of attendanceShareholders who wish to attend the Annual General Meeting must, firstly, be listed in the shareholders' register maintained by Euroclear Sweden AB (the Swedish Central Securities Depository), on Tuesday, 10 April 2018, and secondly, give notice to the company of their intention to attend the meeting no later than Tuesday, 10

Hunter Group ASA: Appendices to notice of extraordinary general meeting to be held on 5 April 2018

Oslo, 12 March 2018: Reference is made to the stock exchange announcement published on 7 March 2018 regarding the notice of an extraordinary general meeting to be held on 5 April 2018 at 11:00 CET. The extraordinary general meeting is held at the request of Apollo Asset Ltd, the holder of approximately 18% of the shares in Hunter Group ASA. The complete notice and appendices are now available at www.huntergroup.no  and are attached to this announcement. This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities

Sectra’s nine-month interim report 2017/2018: Sectra tops customer satisfaction for fifth consecutive year

Linköping, March 12, 2018 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) reported increased order bookings and net sales compared with the year-earlier period. The earnings trend for the Group as a whole was stable. Sectra’s financial focus is to increase its operating profit per share while maintaining its operating margin, and Sectra’s financial performance measures continue to exceed the Group’s target levels.Nine-month period in figures  · Order bookings increased 19.8% to SEK 992.3 million (828.1). · Net sales

There are no items matching the current filter
There are no more items matching the current filter
Back to top